enGene Therapeutics, Inc. (ENGN)
1.56
-0.02
(-1.27%)
USD |
NASDAQ |
Oct 23, 16:00
1.565
0.00 (0.00%)
After-Hours: 20:00
enGene Therapeutics Market Cap : 104.54M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 104.54M |
| October 22, 2026 | 105.88M |
| October 21, 2026 | 109.23M |
| October 20, 2026 | 111.91M |
| October 19, 2026 | 105.88M |
| October 16, 2026 | 111.91M |
| October 15, 2026 | 114.59M |
| October 14, 2026 | 104.54M |
| October 13, 2026 | 109.23M |
| October 12, 2026 | 113.92M |
| October 09, 2026 | 115.93M |
| October 08, 2026 | 119.29M |
| October 07, 2026 | 116.94M |
| October 06, 2026 | 120.63M |
| October 05, 2026 | 125.32M |
| October 02, 2026 | 130.01M |
| October 01, 2026 | 132.69M |
| September 30, 2026 | 134.03M |
| September 29, 2026 | 130.68M |
| September 28, 2026 | 132.02M |
| September 25, 2026 | 131.35M |
| September 24, 2026 | 128.67M |
| September 23, 2026 | 134.03M |
| September 22, 2026 | 137.38M |
| September 21, 2026 | 131.35M |
| Date | Value |
|---|---|
| September 18, 2026 | 128.00M |
| September 17, 2026 | 128.00M |
| September 16, 2026 | 128.00M |
| September 15, 2026 | 126.66M |
| September 14, 2026 | 125.32M |
| September 11, 2026 | 120.63M |
| September 10, 2026 | 118.62M |
| September 09, 2026 | 123.98M |
| September 08, 2026 | 128.67M |
| September 04, 2026 | 121.97M |
| September 03, 2026 | 122.64M |
| September 02, 2026 | 126.61M |
| September 01, 2026 | 124.27M |
| August 31, 2026 | 123.26M |
| August 28, 2026 | 122.26M |
| August 27, 2026 | 127.95M |
| August 26, 2026 | 130.63M |
| August 25, 2026 | 125.27M |
| August 24, 2026 | 121.25M |
| August 21, 2026 | 119.24M |
| August 20, 2026 | 118.57M |
| August 19, 2026 | 123.93M |
| August 18, 2026 | 115.22M |
| August 17, 2026 | 113.88M |
| August 14, 2026 | 113.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals, Inc. | 2.241B |
| Medicus Pharma Ltd. | 150.42M |
| Xenon Pharmaceuticals, Inc. | 3.419B |
| Psyence Biomedical Ltd. | 9.552M |
| Agenus, Inc. | 269.76M |
Market Cap Related Metrics
| PEG Ratio | -0.077 |
| Price to Book Value | 0.454 |
| Price | 1.56 |
| Earnings Yield | -133.3% |
| PEGY Ratio | -0.077 |